BlackRock’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$982K Buy
405,872
+20,564
+5% +$56.1K ﹤0.01% 4352
2025
Q4
$1.68M Buy
385,308
+5,420
+1% +$29.3K ﹤0.01% 4173
2025
Q3
$1.6M Buy
379,888
+54,905
+17% +$195K ﹤0.01% 4164
2025
Q2
$933K Sell
324,983
-24,792
-7% -$65.5K ﹤0.01% 4273
2025
Q1
$944K Buy
349,775
+3,571
+1% +$13.4K ﹤0.01% 4205
2024
Q4
$817K Buy
346,204
+35,917
+12% +$95.5K ﹤0.01% 4272
2024
Q3
$735K Sell
310,287
-97,986
-24% -$216K ﹤0.01% 4245
2024
Q2
$796K Sell
408,273
-823,530
-67% -$2.8M ﹤0.01% 4232
2024
Q1
$7.92M Sell
1,231,803
-65,220
-5% -$592K ﹤0.01% 3466
2023
Q4
$18.2M Buy
1,297,023
+100,900
+8% +$1.59M ﹤0.01% 3064
2023
Q3
$29.3M Buy
1,196,123
+1,053,324
+738% +$26.7M ﹤0.01% 2714
2023
Q2
$4.67M Buy
142,799
+128,298
+885% +$3.61M ﹤0.01% 3747
2023
Q1
$402K Buy
+14,501
New +$235K ﹤0.01% 4584

Other funds holding GNLX

BlackRock's GNLX Position: Q1 2026 in Review

BlackRock increased its Genelux (GNLX) stake by 5.3% in Q1 2026, buying an estimated $56.1K and bringing the position to 405,872 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #4352.

BlackRock first reported a position in GNLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $29.3M in Q3 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • BlackRock held 405,872 shares of Genelux worth $982K as of Q1 2026.
  • BlackRock bought 20,564 Genelux shares in Q1 2026, an estimated $56.1K.
  • Genelux made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4352 holding.
  • BlackRock first reported a position in Genelux in Q1 2023 and has held it in 13 quarters since.
  • BlackRock's Genelux position peaked at $29.3M in Q3 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.